Sofosbuvir / Velpatasvir / Voxilaprevir Side Effects
Applies to sofosbuvir / velpatasvir / voxilaprevir: oral tablet.
Important warnings
This medicine can cause some serious health issues
Oral route (tablet)
Test all patients for evidence of current or prior hepatitis B virus (HBV) infection before initiating treatment with sofosbuvir/velpatasvir/voxilaprevir.
HBV reactivation has been reported in HCV/HBV coinfected patients who were undergoing or had completed treatment with HCV direct-acting antivirals and were not receiving HBV antiviral therapy.
Some cases have resulted in fulminant hepatitis, hepatic failure, and death.
Monitor HCV/HBV coinfected patients for hepatitis flare or HBV reactivation during HCV treatment and post-treatment follow-up.
Initiate appropriate patient management for HBV infection as clinically indicated.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood tests may be needed to check for unwanted effects.
Do not take this medicine together with products containing rifampin (eg, Rifadin®, Rifamate®, Rifater®, Rimactane®). Using these medicines together may cause serious side effects.
If you have ever had a hepatitis B infection, the virus could become active again during treatment with sofosbuvir, velpatasvir, and voxilaprevir combination. You should be tested for hepatitis B infection before starting treatment with this medicine. Talk with your doctor if you have concerns.
This medicine may cause worsening of liver problems. Tell your doctor right away if you have pain or tenderness in the upper stomach, pale stools, dark urine, loss of appetite, nausea, vomiting, or yellow eyes or skin while using this medicine.
Amiodarone can cause serious side effects (including cardiac arrest, slow heartbeat, or conditions that need a pacemaker) if used together with this medicine or other medicines containing sofosbuvir, or if you have used it recently. This is more likely to occur in patients with heart disease or advanced liver disease. Tell your doctor if you are taking amiodarone before using this medicine.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal (eg, St. John's wort) or vitamin supplements.
Other side effects
Some side effects of sofosbuvir / velpatasvir / voxilaprevir may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- diarrhea
- lack or loss of strength
- nausea
Less common side effects
- discouragement
- feeling sad or empty
- irritability
- lack of appetite
- loss of interest or pleasure
- tiredness
- trouble concentrating
- trouble sleeping
Serious side effects
Along with its needed effects, sofosbuvir / velpatasvir / voxilaprevir may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking sofosbuvir / velpatasvir / voxilaprevir:
Incidence not known
- chest pain or discomfort
- dark-colored urine
- headache
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- lightheadedness, dizziness, or fainting
- light-colored stools
- skin rash, sometimes with blisters or hive-like swelling
- slow or irregular heartbeat
- stomach pain, continuing
- unusual tiredness or weakness
- vomiting
- yellow eyes or skin
For healthcare professionals
Applies to sofosbuvir / velpatasvir / voxilaprevir: oral tablet.
General adverse events
The most common side effects reported with this drug were headache, fatigue, diarrhea, and nausea. This drug was permanently discontinued due to side effects in up to 0.2% of patients.[Ref]
Nervous system
- Very common (10% or more): Headache (up to 27%)[Ref]
Other
- Very common (10% or more): Fatigue (up to 24%)
- Common (1% to 10%): Asthenia[Ref]
Gastrointestinal
- Very common (10% or more): Diarrhea (up to 20%), nausea (up to 14%)
- Common (1% to 10%): Elevated lipase, abdominal pain, vomiting[Ref]
Isolated, asymptomatic lipase elevations (greater than 3 times the upper limit of normal [3 x ULN]) were reported in 2% of patients.[Ref]
Hepatic
- Very common (10% or more): Increased total bilirubin (up to 13%)
- Postmarketing reports: Hepatic decompensation, hepatic failure[Ref]
Due to inhibition of OATP1B1 and OATP1B3 by voxilaprevir, increased total bilirubin (up to 1.5 x ULN) occurred with this drug. No jaundice was observed and total bilirubin levels decreased after completion of therapy.
Cases of hepatic decompensation/failure (including fatal outcomes) have been reported during postmarketing experience in patients treated with hepatitis C virus nonstructural protein 3/4A (NS3/4A) protease inhibitor-containing regimens (including this drug). Reported cases occurred in patients with baseline cirrhosis with and without moderate or severe liver dysfunction (Child-Pugh B or C).[Ref]
Psychiatric
- Common (1% to 10%): Insomnia
- Uncommon (0.1% to 1%): Depressed mood[Ref]
Cardiovascular
Sofosbuvir-containing regimens:
- Frequency not reported: Severe bradycardia, heart block
- Postmarketing reports: Serious symptomatic bradycardia (including fatal cardiac arrest, cases requiring pacemaker intervention)[Ref]
Severe bradycardia and heart block have been reported when sofosbuvir-containing regimens were used in combination with amiodarone and/or other agents that lower heart rate.
Serious symptomatic bradycardia has been reported in patients taking amiodarone who started therapy with a regimen containing sofosbuvir.[Ref]
Dermatologic
- Common (1% to 10%): Rash
- Frequency not reported: Stevens-Johnson syndrome
Sofosbuvir-containing regimens:
- Postmarketing reports: Skin rashes (sometimes with blisters or angioedema-like swelling), angioedema[Ref]
Musculoskeletal
- Common (1% to 10%): Back pain, myalgia
- Uncommon (0.1% to 1%): Elevated creatine kinase, muscle spasm[Ref]
Isolated, asymptomatic creatine kinase elevations (at least 10 x ULN) were reported in up to 1% of patients.[Ref]
Metabolic
- Common (1% to 10%): Decreased appetite
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Mavyret
Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Vosevi
Vosevi (sofosbuvir,velpatasvir and voxilaprevir) is used to treat chronic hepatitis C. Includes ...
Glecaprevir/pibrentasvir
Glecaprevir/pibrentasvir (Mavyret) is an oral combination medicine containing fixed doses of 2 ...
Interferon alfa-2b
Interferon alfa-2b systemic is used for angioblastoma, condylomata acuminata, conjunctival ...
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2017) "Product Information. Vosevi (sofosbuvir / velpatasvir / voxilaprevir)." Gilead Sciences
Frequently asked questions
- What are the new drugs for the treatment of hepatitis C?
- How much does Vosevi cost?
- What is the difference between Vosevi and Epclusa?
- Does Vosevi cure hepatitis C?
More about sofosbuvir / velpatasvir / voxilaprevir
- Check interactions
- Compare alternatives
- Reviews (2)
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
- En español
Patient resources
- Sofosbuvir, velpatasvir, and voxilaprevir drug information
- Sofosbuvir, velpatasvir, and voxilaprevir (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Sofosbuvir/velpatasvir/voxilaprevir side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.